The Ohio State University Wexner Medical Center - Center for Neuromodulation
Columbus, Ohio, 43210, United States
NCT Number: NCT01997125
The purpose of this clinical study is to allow the investigation of the Neural Bridging System for participants with tetraplegia to assess if the investigational device can reanimate a paralyzed limb under voluntary control by the participant's thoughts.
Looking for future studies?
Notify Me21 year–89 year
All sexes
Interventional
Not applicable
Columbus, Ohio, 43210, United States
This study plans to enroll participants who have been diagnosed with C4- C6 ASIA A spinal cord injuries (motor and sensory complete neurologic injuries), who are more than 1 year post injury, and who are neurologically stable.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implanted device
Other names: Blackrock Microsystems Neuroport, Neuromuscular Stimulator
Time frame: 9 months
The primary outcome measure of this study is the achievement of voluntary hand movement using the neural bridge system
Marcia Bockbrader
Other
Reanimation in Tetraplegia: Restoring Cortical Control of Functional Movement in Humans With Quadriplegia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07361627
Central Nervous System Diseases, Nervous System Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT07127172
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
London, Greater London, United Kingdom
View Trial DetailsNCT06992596
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT06700304
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Toronto, Ontario, Canada
View Trial Details